Skip to main content
. 2021 Dec 25;14(1):15. doi: 10.3390/toxins14010015

Figure 1.

Figure 1

Plasma accumulation of UTs in patients prescribed at least one OAT1/OAT3 inhibitor (n = 311) vs. patients not prescribed OAT1/OAT3 inhibitors (n = 92) for IxS (A), pCS (B), IAA (C), TMAO (D), together with the eGFR (E). * p < 0.05; ** p < 0.01.